# Molecular Profiling of Advanced Soft-tissue Sarcomas

Source: https://onco.cc/trials/nct03784014/  
OnCo record `nct03784014` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Nilotinib, Ceritinib, Capmatinib, Lapatinib, Trametinib, Olaparib, Palbociclib and Glasdegib in Sarcomas, run by Institut National de la Santé Et de la Recherche Médicale, France, completed.

## Summary

Molecular Profiling of Advanced Soft-tissue Sarcomas is a phase 3 interventional study registered as NCT03784014 by Institut National de la Santé Et de la Recherche Médicale, France, with 603 participants recorded, started 2019-10-19 and reaching its primary completion in 2023-12-01. Interventions recorded: Nilotinib, Ceritinib, Capmatinib, Lapatinib, Trametinib, Trametinib and Dabrafenib, Olaparib and Durvalumab, Palbociclib, Glasdegib, TAS-120, Next Generation sequencing exome. Conditions recorded: Soft Tissue Sarcoma.

Linked to the drug Ceritinib because the registry names it among its interventions and Sarcomas among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03784014
- Phase: 3
- Setting: Molecular Profiling of Advanced Soft-tissue Sarcomas. A Phase III Study
- Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
- Enrolled: 603

## Sources

- ClinicalTrials.gov NCT03784014: https://clinicaltrials.gov/study/NCT03784014

## Connected records

- cancers: [Sarcomas (soft tissue, bone, GIST)](https://onco.cc/cancers/sarcoma/)
- drugs: [Capmatinib](https://onco.cc/drugs/capmatinib/), [Ceritinib](https://onco.cc/drugs/ceritinib/), [Glasdegib](https://onco.cc/drugs/glasdegib/), [Lapatinib](https://onco.cc/drugs/lapatinib/), [Nilotinib](https://onco.cc/drugs/nilotinib/), [Olaparib](https://onco.cc/drugs/olaparib/), [Palbociclib](https://onco.cc/drugs/palbociclib/), [Trametinib](https://onco.cc/drugs/trametinib/)

---
JSON: https://onco.cc/api/v1/entities/nct03784014.json